FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2800792409> ?p ?o ?g. }

• W2800792409 endingPage "8981" @default.
• W2800792409 startingPage "8969" @default.
• W2800792409 abstract "The nucleus pulposus (NP) of intervertebral discs experiences dynamic changes in tissue osmolarity because of diurnal loading of the spine. TonEBP/NFAT5 is a transcription factor that is critical in osmoregulation as well as survival of NP cells in the hyperosmotic milieu. The goal of this study was to investigate whether cyclooxygenase-2 (COX-2) expression is osmoresponsive and dependent on TonEBP, and whether it serves an osmoprotective role. NP cells up-regulated COX-2 expression in hyperosmotic media. The induction of COX-2 depended on elevation of intracellular calcium levels and p38 MAPK pathway, but independent of calcineurin signaling as well as MEK/ERK and JNK pathways. Under hyperosmotic conditions, both COX-2 mRNA stability and its proximal promoter activity were increased. The proximal COX-2 promoter (−1840/+123 bp) contained predicted binding sites for TonEBP, AP-1, NF-κB, and C/EBP-β. While COX-2 promoter activity was positively regulated by both AP-1 and NF-κB, AP-1 had no effect and NF-κB negatively regulated COX-2 protein levels under hyperosmotic conditions. On the other hand, TonEBP was necessary for both COX-2 promoter activity and protein up-regulation in response to hyperosmotic stimuli. Ex vivo disc organ culture studies using hypomorphic TonEBP+/− mice confirmed that TonEBP is required for hyperosmotic induction of COX-2. Importantly, the inhibition of COX-2 activity under hyperosmotic conditions resulted in decreased cell viability, suggesting that COX-2 plays a cytoprotective and homeostatic role in NP cells for their adaptation to dynamically loaded hyperosmotic niches. The nucleus pulposus (NP) of intervertebral discs experiences dynamic changes in tissue osmolarity because of diurnal loading of the spine. TonEBP/NFAT5 is a transcription factor that is critical in osmoregulation as well as survival of NP cells in the hyperosmotic milieu. The goal of this study was to investigate whether cyclooxygenase-2 (COX-2) expression is osmoresponsive and dependent on TonEBP, and whether it serves an osmoprotective role. NP cells up-regulated COX-2 expression in hyperosmotic media. The induction of COX-2 depended on elevation of intracellular calcium levels and p38 MAPK pathway, but independent of calcineurin signaling as well as MEK/ERK and JNK pathways. Under hyperosmotic conditions, both COX-2 mRNA stability and its proximal promoter activity were increased. The proximal COX-2 promoter (−1840/+123 bp) contained predicted binding sites for TonEBP, AP-1, NF-κB, and C/EBP-β. While COX-2 promoter activity was positively regulated by both AP-1 and NF-κB, AP-1 had no effect and NF-κB negatively regulated COX-2 protein levels under hyperosmotic conditions. On the other hand, TonEBP was necessary for both COX-2 promoter activity and protein up-regulation in response to hyperosmotic stimuli. Ex vivo disc organ culture studies using hypomorphic TonEBP+/− mice confirmed that TonEBP is required for hyperosmotic induction of COX-2. Importantly, the inhibition of COX-2 activity under hyperosmotic conditions resulted in decreased cell viability, suggesting that COX-2 plays a cytoprotective and homeostatic role in NP cells for their adaptation to dynamically loaded hyperosmotic niches." @default.
• W2800792409 created "2018-05-17" @default.
• W2800792409 creator A5002960414 @default.
• W2800792409 creator A5012718663 @default.
• W2800792409 creator A5018229569 @default.
• W2800792409 creator A5019521528 @default.
• W2800792409 creator A5047077896 @default.
• W2800792409 creator A5060059129 @default.
• W2800792409 creator A5067535436 @default.
• W2800792409 creator A5078697384 @default.
• W2800792409 date "2018-06-01" @default.
• W2800792409 modified "2023-10-16" @default.
• W2800792409 title "COX-2 expression mediated by calcium-TonEBP signaling axis under hyperosmotic conditions serves osmoprotective function in nucleus pulposus cells" @default.
• W2800792409 cites W1492812051 @default.
• W2800792409 cites W1582604680 @default.
• W2800792409 cites W1970509697 @default.
• W2800792409 cites W1979727148 @default.
• W2800792409 cites W1987834954 @default.
• W2800792409 cites W1996888339 @default.
• W2800792409 cites W1997222309 @default.
• W2800792409 cites W2000800166 @default.
• W2800792409 cites W2004827058 @default.
• W2800792409 cites W2014209078 @default.
• W2800792409 cites W2022585333 @default.
• W2800792409 cites W2025163249 @default.
• W2800792409 cites W2025512024 @default.
• W2800792409 cites W2025699489 @default.
• W2800792409 cites W2028846949 @default.
• W2800792409 cites W2033848237 @default.
• W2800792409 cites W2034467929 @default.
• W2800792409 cites W2035168899 @default.
• W2800792409 cites W2041713757 @default.
• W2800792409 cites W2044685101 @default.
• W2800792409 cites W2050859612 @default.
• W2800792409 cites W2051122971 @default.
• W2800792409 cites W2065843409 @default.
• W2800792409 cites W2067405328 @default.
• W2800792409 cites W2084500594 @default.
• W2800792409 cites W2092798278 @default.
• W2800792409 cites W2100684141 @default.
• W2800792409 cites W2102060614 @default.
• W2800792409 cites W2114970772 @default.
• W2800792409 cites W2115024795 @default.
• W2800792409 cites W2122900984 @default.
• W2800792409 cites W2124815383 @default.
• W2800792409 cites W2129713711 @default.
• W2800792409 cites W2131015766 @default.
• W2800792409 cites W2133196171 @default.
• W2800792409 cites W2146617670 @default.
• W2800792409 cites W2161538812 @default.
• W2800792409 cites W2168207023 @default.
• W2800792409 cites W2170016400 @default.
• W2800792409 cites W2170935967 @default.
• W2800792409 cites W2172773199 @default.
• W2800792409 cites W2229330024 @default.
• W2800792409 cites W2267308669 @default.
• W2800792409 cites W2272023237 @default.
• W2800792409 cites W2556479463 @default.
• W2800792409 cites W2725056820 @default.
• W2800792409 cites W2748679585 @default.
• W2800792409 cites W2793317942 @default.
• W2800792409 cites W2795272815 @default.
• W2800792409 doi "https://doi.org/10.1074/jbc.ra117.001167" @default.
• W2800792409 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5995512" @default.
• W2800792409 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29700115" @default.
• W2800792409 hasPublicationYear "2018" @default.
• W2800792409 type Work @default.
• W2800792409 sameAs 2800792409 @default.
• W2800792409 citedByCount "23" @default.
• W2800792409 countsByYear W28007924092018 @default.
• W2800792409 countsByYear W28007924092019 @default.
• W2800792409 countsByYear W28007924092020 @default.
• W2800792409 countsByYear W28007924092021 @default.
• W2800792409 countsByYear W28007924092022 @default.
• W2800792409 countsByYear W28007924092023 @default.
• W2800792409 crossrefType "journal-article" @default.
• W2800792409 hasAuthorship W2800792409A5002960414 @default.
• W2800792409 hasAuthorship W2800792409A5012718663 @default.
• W2800792409 hasAuthorship W2800792409A5018229569 @default.
• W2800792409 hasAuthorship W2800792409A5019521528 @default.
• W2800792409 hasAuthorship W2800792409A5047077896 @default.
• W2800792409 hasAuthorship W2800792409A5060059129 @default.
• W2800792409 hasAuthorship W2800792409A5067535436 @default.
• W2800792409 hasAuthorship W2800792409A5078697384 @default.
• W2800792409 hasBestOaLocation W28007924091 @default.
• W2800792409 hasConcept C104317684 @default.
• W2800792409 hasConcept C129900496 @default.
• W2800792409 hasConcept C168529131 @default.
• W2800792409 hasConcept C185592680 @default.
• W2800792409 hasConcept C51551487 @default.
• W2800792409 hasConcept C55493867 @default.
• W2800792409 hasConcept C57074206 @default.
• W2800792409 hasConcept C62478195 @default.
• W2800792409 hasConcept C86339819 @default.
• W2800792409 hasConcept C86803240 @default.
• W2800792409 hasConcept C95444343 @default.
• W2800792409 hasConceptScore W2800792409C104317684 @default.
• W2800792409 hasConceptScore W2800792409C129900496 @default.

• next